FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate

BACKGROUND: Patients with bipolar disorder are at high risk of metabolic disturbance after mood stabilizer treatment. However, the mediators linking the two conditions remain unknown. In this study, we investigated whether fibroblast growth factor-21 (FGF21) was associated with metabolic effects and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hui Hua, Chen, Po See, Cheng, Yung Wen, Wang, Tzu-Yun, Yang, Yen Kuang, Lu, Ru-Band
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888470/
https://www.ncbi.nlm.nih.gov/pubmed/29618013
http://dx.doi.org/10.1093/ijnp/pyx093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888470/
https://www.ncbi.nlm.nih.gov/pubmed/29618013
http://dx.doi.org/10.1093/ijnp/pyx093

Ejemplares similares